58 master-"https:" "https:" "https:" "https:" "UCL" Fellowship positions at Northeastern University in United States
Sort by
Refine Your Search
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Clinical-Science-Postdoctoral-Research
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Ironwood-Pharmaceuticals-Regulatory-Affairs-Postdoctoral
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Global-Patient-Safety-and-Risk
-
. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Regulatory-Affairs-Postdoctoral-Research-Fellow_R135528 Copyright 2025
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Global-Medical-Affairs-TTR
-
to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines
-
bring their authentic selves to work, and achieve their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking
-
, wellness & life, retirement- as well as commuting & transportation. Visit https://hr.northeastern.edu/benefits/ for more information. All qualified applicants are encouraged to apply and will receive
-
. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/CSL-Seqirus-Medical-Affairs-Postdoctoral-Research-Fellow_R135293 Copyright 2025 Jobelephant.com Inc. All
-
, acquired, life-threatening blood disorder, and an approved therapy for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), two rare and serious kidney